As on Wednesday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) got off with the flyer as it spiked 3.81% to $12.52, before settling in for the price of $12.06 at the close. Taking a more long-term approach, OLMA posted a 52-week range of $8.51-$17.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -105.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.57%. This publicly-traded company’s shares outstanding now amounts to $54.99 million, simultaneously with a float of $49.24 million. The organization now has a market capitalization sitting at $716.97 million. At the time of writing, stock’s 50-day Moving Average stood at $12.03, while the 200-day Moving Average is $12.15.
Olema Pharmaceuticals Inc (OLMA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Olema Pharmaceuticals Inc’s current insider ownership accounts for 14.02%, in contrast to 88.17% institutional ownership. According to the most recent insider trade that took place on Aug 01 ’24, this organization’s 10% Owner sold 2,400,000 shares at the rate of 14.91, making the entire transaction reach 35,796,000 in total value, affecting insider ownership by 783,118. Preceding that transaction, on Jul 29 ’24, Company’s Director sold 4,066 for 15.58, making the whole transaction’s value amount to 63,348. This particular insider is now the holder of 752,217 in total.
Olema Pharmaceuticals Inc (OLMA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
Olema Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -6.57% and is forecasted to reach -2.60 in the upcoming year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Let’s observe the current performance indicators for Olema Pharmaceuticals Inc (OLMA). It’s Quick Ratio in the last reported quarter now stands at 9.13. The Stock has managed to achieve an average true range (ATR) of 0.65.
In the same vein, OLMA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.06, a figure that is expected to reach -0.57 in the next quarter, and analysts are predicting that it will be -2.60 at the market close of one year from today.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Through scrutinizing the latest numbers posted by the [Olema Pharmaceuticals Inc, OLMA], it can be observed that its last 5-days Average volume of 0.4 million was lower the volume of 0.74 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 59.66% While, its Average True Range was 0.66.
Raw Stochastic average of Olema Pharmaceuticals Inc (OLMA) in the period of the previous 100 days is set at 36.63%, which indicates a major fall in contrast to 57.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 36.95% that was lower than 60.45% volatility it exhibited in the past 100-days period.
